<SEC-DOCUMENT>0001104659-22-043219-index.html : 20220406 <SEC-HEADER>0001104659-22-043219.hdr.sgml : 20220406 <ACCEPTANCE-DATETIME>20220406161108 ACCESSION NUMBER: 0001104659-22-043219 CONFORMED SUBMISSION TYPE: PRE 14A PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20220524 FILED AS OF DATE: 20220406 DATE AS OF CHANGE: 20220406 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Marker Therapeutics, Inc. CENTRAL INDEX KEY: 0001094038 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 880277072 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: PRE 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37939 FILM NUMBER: 22810681 BUSINESS ADDRESS: STREET 1: 3200 SOUTHWEST FREEWAY STREET 2: SUITE 2500 CITY: HOUSTON STATE: TX ZIP: 77027 BUSINESS PHONE: (713) 400-6400 MAIL ADDRESS: STREET 1: 3200 SOUTHWEST FREEWAY STREET 2: SUITE 2500 CITY: HOUSTON STATE: TX ZIP: 77027 FORMER COMPANY: FORMER CONFORMED NAME: TAPIMMUNE INC. DATE OF NAME CHANGE: 20170629 FORMER COMPANY: FORMER CONFORMED NAME: TAPIMMUNE INC DATE OF NAME CHANGE: 20070628 FORMER COMPANY: FORMER CONFORMED NAME: GENEMAX CORP DATE OF NAME CHANGE: 20020718 </SEC-HEADER> <DOCUMENT> <TYPE>PRE 14A <SEQUENCE>1 <FILENAME>tm2211212-1_pre14a.htm <DESCRIPTION>PRE 14A <TEXT> Document 1 - file: tm2211212-1_pre14a.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>lg_markertherapeutics-4clr.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 2 - file: lg_markertherapeutics-4clr.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>sg_michael-4c.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: sg_michael-4c.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>tm2211212d1-px_page01bw.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: tm2211212d1-px_page01bw.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>tm2211212d1-px_page02bw.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: tm2211212d1-px_page02bw.jpg
</DOCUMENT> </SEC-DOCUMENT>